Lausanne, May 21th, 2019. Saphetor SA, a Swiss precision medicine company and the creator of VarSome, a suite of advanced bioinformatics solutions, announced today a partnership with Molecular Vision Laboratory (MVL), a CAP and CLIA-certified medical diagnostic laboratory based in Oregon, USA, providing comprehensive genetic NGS-based testing for inherited retinal dystrophies.
As a result of little standardization, large amount of new scientific findings generated almost every day and an explosion of sequencing data for various purposes, the landscape of human genomics is quite fragmented, siloed, and inconsistent. We all know how frustrating the process of assessing a comprehensive information for genomic variant can be. The way forward is data integration, harmonization and cross-referencing.
The Saphetor Portal has been updated to version 7 as of February 2nd 2019 under the new name VarSome Clinical. There are many changes since version 6, and this release brings our clinical platform up to date with the features, databases and classification visible in the free VarSome.com. Our clinical platform has been on the market since 2015 and is already being used by dozens of institutional clients, such as diagnostic laboratories, hospitals, and universities from countries all over the world.
New York and Lausanne, Switzerland - January 10, 2019 - Saphetor SA, the creator of VarSome, announced today a partnership with the Englander Institute for Precision Medicine at Weill Cornell Medicine, the creator of Precision Medicine Knowledgebase (PMKB), a curated resource for the clinical interpretation of cancer variants . PMKB is now a fundamental component of VarSome’s portfolio of over 30 integrated and cross-referenced public data resources as well as VarSome’s implementation of the American College of Medical Genetics guidelines.